FDA Needs To Put Meaning Behind “Clinically Meaningful,” Lipicky Says
Executive Summary
FDA's increasing requirements for clinical meaningfulness in efficacy measures make it more difficult to predict the agency's regulatory actions, former division director Ray Lipicky says